Oregon Physicians Urge State Commission to Approve Use of 3-D Mammography Machines for Medicaid Reimbursement

Friday, March 10, 2017

The Bend (OR) Bulletin (3/9, Bannow) reports all of Central Oregon’s imaging providers have switched to 3-D mammography machines after the federal government approved their usage. The Bulletin writes, “At its meeting Thursday, the commission that decides what OHP covers may vote on whether the program will pay for 3-D mammography for women ages 40 to 74 with an average breast cancer risk. The program for low-income individuals currently covers 2-D mammography for that population.” Physicians in Oregon point to studies demonstrating the effectiveness of 3-D machines as reasons for the need to cover the procedures, and they also pointed to claims that the switch could save the state $8.14 per scan. 

New York Insurers Must Cover “Medically Necessary” 3-D Mammograms Under New State Law

Friday, March 3, 2017

Newsday (NY) (3/2, Ricks) reports New York health insurers “must cover ‘medically necessary’ high-tech 3-D mammograms without copays, coinsurance or deductibles under a new state law.” A spokesperson for Gov. Andrew Cuomo clarified on Thursday that “the new payment rules apply when” a 3-D mammography test “is deemed ‘medically necessary as determined by a physician.’” 

Study Looks at Patient Satisfaction with Performance of US Radiologists

Wednesday, February 22, 2017

The Radiology Business Journal (2/21, Maglaya) reports that researchers found that in a study of patient “satisfaction with the performance of U.S. radiologists, results” were “favorable.” The findings were published in the American Journal of Roentgenology. 

At Least Five States Have Introduced Legislation Requiring Insurers to Cover DBT

Wednesday, February 22, 2017

The Radiology Business Journal (2/17, Doss) reported, “At least five states,” including Maryland, New Hampshire, New Jersey, New York, and Texas, “have introduced legislation requiring insurers to cover Digital Breast Tomosynthesis.” The Journal added, “The economic and clinical benefits of DBT are well-established, but the passage of the bills may come down the legislative climate of the individual states, according to Eugenia Brandt, Director of State Affairs for the American College of Radiology.” 

FDA Updates Guidance on DBT, MQSA Training Requirements

Wednesday, February 22, 2017
Meeting the new modality training requirements for DBT just got easier. On Feb. 6, 2017, the FDA revised its FAQs about DBT and MQSA training requirements, so manufacturer-specific DBT training is no longer required. Now training is only required on one DBT system — or personnel can just receive general DBT training.